.Along with early stage 1 data today out in the wild, metabolic health condition outfit Metsera is l...
.Rivus Pharmaceuticals has actually unveiled the records responsible for its period 2 obesity gain i...
.Bristol Myers Squibb is actually paying Best Medication $110 million ahead of time to develop reage...
.Novartis has inked a bargain possibly worth more than $1 billion with Flagship-founded Generate: Bi...
.Recently debuted Metsera is actually unfolding some stage 1 data for its own GLP-1 receptor agonist...
.Surrounded by the hereditary medications arms race, Front runner Pioneering is actually revealing a...
.BioAge Labs is eyeing about $180 thousand in preliminary profits coming from an IPO and also an exc...
.An effort through Merck & Co. to open the microsatellite steady (MSS) metastatic colon cancer ce...
.Spain-based Asabys Allies has shut a fund of 180 million euros ($ 200 million), loan that will defi...
.BioAge Labs is introducing just about $200 million via its own Nasdaq IPO this morning, along with ...